![Neil Robinson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Neil Robinson
Corporate Officer/Principal presso MNLpharma Ltd.
Profilo
Neil Robinson is Director of Development for MNLpharma Ltd.
Previously, he was the Head of Analytical Chemistry for Xenova Group Plc.
Mr. Robinson holds a PhD degree.
Posizioni attive di Neil Robinson
Società | Posizione | Inizio |
---|---|---|
MNLpharma Ltd.
![]() MNLpharma Ltd. Pharmaceuticals: MajorHealth Technology MNLpharma Ltd. develops and sells pharmaceuticals. It offers therapeutic products, research equipment, and related services. The company developed a molecule Immunomodulators for the treatment of cancer, infectious diseases, and immune disorders. It was founded in 1999 and is headquartered in Aberystwyth, UK | Corporate Officer/Principal | 01/04/2000 |
Precedenti posizioni note di Neil Robinson
Società | Posizione | Fine |
---|---|---|
Xenova Group Plc
![]() Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Xenova Group Plc researches and develops pharmaceutical products. The company is focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. It has pipeline of drug candidates in clinical development including a novel program for the treatment of high-grade glioma and TransMID. The company was founded in 1987 and is headquartered in Slough, UK | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
MNLpharma Ltd.
![]() MNLpharma Ltd. Pharmaceuticals: MajorHealth Technology MNLpharma Ltd. develops and sells pharmaceuticals. It offers therapeutic products, research equipment, and related services. The company developed a molecule Immunomodulators for the treatment of cancer, infectious diseases, and immune disorders. It was founded in 1999 and is headquartered in Aberystwyth, UK | Health Technology |
Xenova Group Plc
![]() Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Xenova Group Plc researches and develops pharmaceutical products. The company is focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. It has pipeline of drug candidates in clinical development including a novel program for the treatment of high-grade glioma and TransMID. The company was founded in 1987 and is headquartered in Slough, UK | Commercial Services |
- Borsa valori
- Insiders
- Neil Robinson